Abstract:ABSTRACT Naringenin is the central flavonoid in the biosynthesis of several bioactive compounds and presents a growing demand for its nutraceutical properties. Naringenin extraction from plants is non-viable due to low yields, and microbial platforms could represent a controlled and sustained alternative to produce it using several metabolic engineering tools. This study shows the naringenin production in Saccharomyces cerevisiae from glucose through a combined approach of systems biology, enzyme criteria selection, and a molecular engineering strategy. In silico prediction using a mixed integer linear programming (MILP) algorithm showed that the phenylpropanoid pathway was the shortest and most viable metabolic pathway. Two biscistronic constructs were generated using the PTV-1 2A peptide sequence, and a naringenin biofactory was assembled with the phenylalanine ammonia-lyase/tyrosine ammonia-lyase genes encoding phenylalanine/tyrosine ammonia-lyase ( Rhodobacter capsulatus ), 4-coumaroyl (4 Cl) encoding a p -coumaroyl-CoA ligase ( Solanum lycopersicum ), CHS encoding chalcone synthase ( Hypericum androsaemum ), and CHI encoding a chalcone isomerase ( Glycine max ). Naringenin productivity in batch fermentation was about 40.67 ± 3.47 μg/Lh with a 6.10 ± 0.52 mg/L titer (22.41 ± 1.91 μM) and a 3.26 ± 1.36 mg/g yield ( Y P / S ) with the detection of additional flavonoids. The obtained concentration is better than other related works in diverse engineered microorganisms. The results suggest a successful and optimizable alternative for the heterologous flavanone production in yeast combined with bicistronic expression mediated by a 2A peptide sequence for the first time. This strategy supports the production of extensive routes for other nutraceutical compounds. IMPORTANCE Flavonoids are a group of compounds generally produced by plants with proven biological activity, which have recently beeen recommended for the treatment and prevention of diseases and ailments with diverse causes. In this study, naringenin was produced in adequate amounts in yeast after in silico design. The four genes of the involved enzymes from several organisms (bacteria and plants) were multi-expressed in two vectors carrying each two genes linked by a short viral peptide sequence. The batch kinetic behavior of the product, substrate, and biomass was described at lab scale. The engineered strain might be used in a more affordable and viable bioprocess for industrial naringenin procurement.

Metabolically engineering of Yarrowia lipolytica for the biosynthesis of naringenin from a mixture of glucose and xylose

Metabolic engineering of <i>Yarrowia lipolytica</i> for liquiritigenin production

Efficient Production of Xylitol by the Integration of Multiple Copies of Xylose Reductase Gene and the Deletion of Embden–Meyerhof–Parnas Pathway-Associated Genes to Enhance NADPH Regeneration in Escherichia Coli

Increasing NADPH Availability for Xylitol Production via Pentose-Phosphate-Pathway Gene Overexpression and Embden-Meyerhof-Parnas-Pathway Gene Deletion in <i>Escherichia coli</i>

Heterologous Biosynthesis of Taxifolin in Yarrowia lipolytica: Metabolic Engineering and Genome-Scale Metabolic Modeling

Multiplex modification of Yarrowia lipolytica for enhanced erythritol biosynthesis from glycerol through modularized metabolic engineering

Enabling xylose utilization in Yarrowia lipolytica for lipid production

Systematically Engineered Fatty Acid Catabolite Pathway for the Production of (2 S )-Naringenin in Saccharomyces cerevisiae

Metabolic engineering of Acinetobacter baylyi ADP1 for naringenin production

Fermentation and Metabolic Pathway Optimization to De Novo Synthesize (2S)-Naringenin in Escherichia coli

Leveraging a Y. lipolytica naringenin chassis for biosynthesis of apigenin and associated glucoside

Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli

Saccharomyces cerevisiae biofactory to produce naringenin using a systems biology approach and a bicistronic vector expression strategy in flavonoid production

Emerging Technologies for HIV Prevention for MSM: What We have Learned, and Ways Forward

De Novo Synthesis of Resveratrol from Sucrose by Metabolically Engineered Yarrowia lipolytica

Combinatorial Modulation of Linalool Synthase and Farnesyl Diphosphate Synthase for Linalool Overproduction in <i>Saccharomyces cerevisiae</i>

Optimizing Oleaginous Yeast Cell Factories for Flavonoids and Hydroxylated Flavonoids Biosynthesis

Remodelling metabolism for high-level resveratrol production in Yarrowia lipolytica

Enhancing precursor supply and modulating metabolism to achieve high-level production of β-farnesene in Yarrowia lipolytica

Installing xylose assimilation and cellodextrin phosphorolysis pathways in obese Yarrowia lipolytica facilitates cost-effective lipid production from lignocellulosic hydrolysates

Improving an Alternative Glycerol Catabolism Pathway in Yarrowia lipolytica to Enhance Erythritol Production